Novel Compounds for Preventing SARS-CoV-2 Viral Replication and Treating COVID-19.

Published in: ACS medicinal chemistry letters (2023)

Provided herein are novel compounds as SARS-CoV-2-related 3C-like protease inhibitors, pharmaceutical compositions, use of such compounds in preventing SARS-CoV-2 viral replication and treating COVID-19, and processes for preparing such compounds.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
drug induced